Literature DB >> 16113284

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.

Hyun-Jeong Ko1, Sung-Youl Ko, Yeon-Jeong Kim, Eun-Gae Lee, Sang-Nae Cho, Chang-Yuil Kang.   

Abstract

In spite of its many other benefits, DNA vaccine is limited in its application by its insufficient immunogenicity. One promising approach for enhancing its immunogenicity is to maximize its expression in the immunized host. In the current study, we investigated whether codon optimization of the mycobacterial antigen Ag85B gene could enhance the expression and immunogenicity of the Ag85B DNA vaccine. We generated a synthetic humanized Ag85B (hAg85B) gene in which codon usage was optimized for expression in human cells. DNA plasmids with codon-optimized hAg85B increased the level of protein expression in vitro and in vivo. DNA vaccine with hAg85B induced stronger Th1-like and cytotoxic T-cell immune responses in BALB/c mice and generated higher protective immunity in a BALB/c mouse model of Mycobacterium tuberculosis aerosol infection than did the DNA vaccine with wild-type Ag85B. Therefore, our results suggest that codon optimization of mycobacterial antigens (e.g., Ag85B) could improve protein expression and thereby enhance the immunogenicity of DNA vaccines against M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113284      PMCID: PMC1231050          DOI: 10.1128/IAI.73.9.5666-5674.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Codon usage tabulated from international DNA sequence databases: status for the year 2000.

Authors:  Y Nakamura; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  DNA vaccines: immunology, application, and optimization*.

Authors:  S Gurunathan; D M Klinman; R A Seder
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus.

Authors:  R Stratford; G Douce; L Zhang-Barber; N Fairweather; J Eskola; G Dougan
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

4.  Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo.

Authors:  Jyh-Chiang E Wang; Alexandra M Livingstone
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 5.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

6.  Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases.

Authors:  S Sasaki; R R Amara; A E Oran; J M Smith; H L Robinson
Journal:  Nat Biotechnol       Date:  2001-06       Impact factor: 54.908

7.  Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium.

Authors:  M Uchijima; A Yoshida; T Nagata; Y Koide
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

8.  Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.

Authors:  T W Kim; C-F Hung; J Juang; L He; J M Hardwick; T-C Wu
Journal:  Gene Ther       Date:  2004-02       Impact factor: 5.250

9.  Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

Authors:  R Wang; D L Doolan; T P Le; R C Hedstrom; K M Coonan; Y Charoenvit; T R Jones; P Hobart; M Margalith; J Ng; W R Weiss; M Sedegah; C de Taisne; J A Norman; S L Hoffman
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

10.  Improved tuberculosis DNA vaccines by formulation in cationic lipids.

Authors:  S D'Souza; V Rosseels; O Denis; A Tanghe; N De Smet; F Jurion; K Palfliet; N Castiglioni; A Vanonckelen; C Wheeler; K Huygen
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  21 in total

1.  Alphavirus replicon approach to promoterless analysis of IRES elements.

Authors:  K I Kamrud; M Custer; J M Dudek; G Owens; K D Alterson; J S Lee; J L Groebner; J F Smith
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

2.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

Review 3.  DNA vaccines: developing new strategies to enhance immune responses.

Authors:  Shaheed A Abdulhaqq; David B Weiner
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

5.  Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.

Authors:  Osmarie Martínez; Ariana Bravo Cruz; Saritza Santos; Maite Ramírez; Eric Miranda; Joanna Shisler; Miguel Otero
Journal:  Vaccine       Date:  2017-06-16       Impact factor: 3.641

6.  Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.

Authors:  Yiling Zhang; Liqiang Feng; Liang Li; Dimin Wang; Chufang Li; Caijun Sun; Pingchao Li; Xuehua Zheng; Yichu Liu; Wei Yang; Xuefeng Niu; Nanshan Zhong; Ling Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Bioinformatics in new generation flavivirus vaccines.

Authors:  Penelope Koraka; Byron E E Martina; Albert D M E Osterhaus
Journal:  J Biomed Biotechnol       Date:  2010-05-10

8.  Analysis of synonymous codon usage in Zea mays.

Authors:  Hanmei Liu; Rui He; Huaiyu Zhang; Yubi Huang; Mengliang Tian; Junjie Zhang
Journal:  Mol Biol Rep       Date:  2009-03-29       Impact factor: 2.316

9.  Immunomodulator-based enhancement of anti smallpox immune responses.

Authors:  Osmarie Martínez; Eric Miranda; Maite Ramírez; Saritza Santos; Carlos Rivera; Luis Vázquez; Tomás Sánchez; Raymond L Tremblay; Eddy Ríos-Olivares; Miguel Otero
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

10.  Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.

Authors:  Amanda J Williams; Lyn M O'Brien; Robert J Phillpotts; Stuart D Perkins
Journal:  Virol J       Date:  2009-07-31       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.